The results showed that TPD52L2 might regulate multiple tumor progression-related signaling pathways, such as the PI3K−Akt signaling pathway, IL−17 signaling pathway, Wnt signaling pathway, and Hippo signaling pathway. Here, IL17A is linked to neoplasm.